<DOC>
	<DOCNO>NCT00993135</DOCNO>
	<brief_summary>RATIONALE : Gathering information often kidney dysfunction occur child young adult receive methotrexate acute lymphoblastic leukemia may help doctor learn disease plan best treatment . PURPOSE : This research study look kidney dysfunction child young adult receive low-dose intermediate-dose methotrexate acute lymphoblastic leukemia .</brief_summary>
	<brief_title>Kidney Dysfunction Children Young Adults Who Have Received Methotrexate Acute Lymphoblastic Leukemia</brief_title>
	<detailed_description>OBJECTIVES : - Examine incidence renal dysfunction child young adult treat acute lymphoblastic leukemia low- intermediate-dose methotrexate . OUTLINE : Medical chart review obtain following information : gender , age , diagnosis , regimen , day therapy , renal function , creatinine level , mucositis , skin sloughing , methotrexate level high level , number day intravenous methotrexate .</detailed_description>
	<mesh_term>Leukemia</mesh_term>
	<mesh_term>Precursor Cell Lymphoblastic Leukemia-Lymphoma</mesh_term>
	<mesh_term>Leukemia , Lymphoid</mesh_term>
	<mesh_term>Methotrexate</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Diagnosis acute lymphoblastic leukemia Receiving low intermediatedose methotrexate receive treatment ( chemotherapy and/or radiation ) Vanderbilt Children 's Hospital PATIENT CHARACTERISTICS : Not specify PRIOR CONCURRENT THERAPY : See Disease Characteristics</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>21 Years</maximum_age>
	<verification_date>April 2017</verification_date>
	<keyword>renal toxicity</keyword>
	<keyword>childhood acute lymphoblastic leukemia</keyword>
	<keyword>adult acute lymphoblastic leukemia</keyword>
</DOC>